(Q52953121)
Statements
A comparison of the biologic activity of two recombinant IFN-beta preparations used in the treatment of relapsing-remitting multiple sclerosis. (English)
1 reference
Francesco Antonetti
1 reference
Ornella Finocchiaro
1 reference
Michele Mascia
1 reference
Maria Grazia Terlizzese
1 reference
Amer Jaber
1 reference
1 December 2002
1 reference
22
1 reference
1181-1184
1 reference
12
1 reference